advertisement
5.3 Other (39)
Showing records 1 to 25
Display all abstracts in classification 5.3 Other
Search within classification 5.3 Other85079 Non-contact determination of intra-ocular pressure in an ex vivo porcine model
Salmi A
PLoS ONE 2020; 15: e0227488
84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Yamamoto K
Scientific reports 2019; 9: 19288
84795 Effects of Regorafenib, a Multi-Kinase Inhibitor, on Conjunctival Scarring in a Canine Filtration Surgery Model in Comparison with Mitomycin-C
Nemoto E
International journal of molecular sciences 2019; 21:
84853 Study of minimally invasive radiofrequency ablation of the ciliary body for the treatment of glaucoma in rabbits
Hou B
Molecular medicine reports 2020; 21: 1071-1076
84241 Effects of rosiglitazone/PHBV drug delivery system on postoperative fibrosis in rabbit glaucoma filtration surgery model
Zhang F
Drug Delivery 2019; 26: 812-819
84853 Study of minimally invasive radiofrequency ablation of the ciliary body for the treatment of glaucoma in rabbits
Wang F
Molecular medicine reports 2020; 21: 1071-1076
84241 Effects of rosiglitazone/PHBV drug delivery system on postoperative fibrosis in rabbit glaucoma filtration surgery model
Liu K
Drug Delivery 2019; 26: 812-819
85079 Non-contact determination of intra-ocular pressure in an ex vivo porcine model
Nieminen HJ
PLoS ONE 2020; 15: e0227488
84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Kokubun T
Scientific reports 2019; 9: 19288
84795 Effects of Regorafenib, a Multi-Kinase Inhibitor, on Conjunctival Scarring in a Canine Filtration Surgery Model in Comparison with Mitomycin-C
Kojima S; Sugiyama T
International journal of molecular sciences 2019; 21:
84241 Effects of rosiglitazone/PHBV drug delivery system on postoperative fibrosis in rabbit glaucoma filtration surgery model
Pan Z
Drug Delivery 2019; 26: 812-819
84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Sato K
Scientific reports 2019; 9: 19288
84853 Study of minimally invasive radiofrequency ablation of the ciliary body for the treatment of glaucoma in rabbits
Ye Z
Molecular medicine reports 2020; 21: 1071-1076
85079 Non-contact determination of intra-ocular pressure in an ex vivo porcine model
Veira Canle D
PLoS ONE 2020; 15: e0227488
84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Akaishi T
Scientific reports 2019; 9: 19288
84795 Effects of Regorafenib, a Multi-Kinase Inhibitor, on Conjunctival Scarring in a Canine Filtration Surgery Model in Comparison with Mitomycin-C
Jin D
International journal of molecular sciences 2019; 21:
84853 Study of minimally invasive radiofrequency ablation of the ciliary body for the treatment of glaucoma in rabbits
Jin X
Molecular medicine reports 2020; 21: 1071-1076
85079 Non-contact determination of intra-ocular pressure in an ex vivo porcine model
Hæggström E
PLoS ONE 2020; 15: e0227488
84241 Effects of rosiglitazone/PHBV drug delivery system on postoperative fibrosis in rabbit glaucoma filtration surgery model
Cao M
Drug Delivery 2019; 26: 812-819
84853 Study of minimally invasive radiofrequency ablation of the ciliary body for the treatment of glaucoma in rabbits
Fu Y
Molecular medicine reports 2020; 21: 1071-1076
85079 Non-contact determination of intra-ocular pressure in an ex vivo porcine model
Kontiola A
PLoS ONE 2020; 15: e0227488
84241 Effects of rosiglitazone/PHBV drug delivery system on postoperative fibrosis in rabbit glaucoma filtration surgery model
Zhou D
Drug Delivery 2019; 26: 812-819
84795 Effects of Regorafenib, a Multi-Kinase Inhibitor, on Conjunctival Scarring in a Canine Filtration Surgery Model in Comparison with Mitomycin-C
Takai S
International journal of molecular sciences 2019; 21:
84772 The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery
Shimazaki A
Scientific reports 2019; 9: 19288
84795 Effects of Regorafenib, a Multi-Kinase Inhibitor, on Conjunctival Scarring in a Canine Filtration Surgery Model in Comparison with Mitomycin-C
Maeda M
International journal of molecular sciences 2019; 21:
